Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.
复制标题
DOI:
10.1086/591629
复制
发表时间:
2008-10-01
期刊:
影响因子:
--
通讯作者:
Rodriguez-Barradas MC
中科院分区:
文献类型:
--
作者:
Musher DM;Rueda AM;Nahm MH;Graviss EA;Rodriguez-Barradas MC
Controversy persists over the benefits of pneumococcal polysaccharide vaccine (PPV) in at-risk adults. We studied PPV, protein-conjugate pneumococcal vaccine (PCV), or immunologic ‘priming’ with PCV followed by ‘boosting’ with PPV in adults who recovered from pneumococcal pneumonia. Subjects received PPV followed in 6 months by PCV, or vice-versa. IgG to capsular polysaccharide and opsonophagocytic killing activity (OPK) were studied at baseline, 4–8 weeks and 6 months after each vaccination. PPV and PCV stimulated similar IgG levels and OPK at 4–8 weeks. Six months post-PPV, antibody declined to baseline but remained modestly elevated post-PCV. PCV given 6 months post-PPV stimulated modest IgG increases that failed to reach post-PPV peaks. In contrast, PPV 6 months after PCV caused dramatic increases in IgG and OPK to all polysaccharides, consistent with a booster effect. Six months after the second vaccination, however, IgG and OPK in all patients fell precipitously, returning toward original baseline levels. In high-risk subjects, the effect of PPV is short-lived; PCV stimulates a more prolonged response. PPV as a booster following PCV causes early antibody rises, but IgG declines rapidly thereafter, consistent with induction of suppressor cells or tolerance. Protein vaccines may be needed for high-risk adults.
登录
查看更多内容
影响因子:
3.6
作者:
Black, S;Shinefield, H;Edwards, K
通讯作者:
Edwards, K
影响因子:
6.4
作者:
Ahmed, F;Steinhoff, MC;Nelson, KE
通讯作者:
Nelson, KE
影响因子:
5.5
作者:
Jackson, Lisa A.;Neuzil, Kathleen M.;Carlone, George M.
通讯作者:
Carlone, George M.
DOI:
10.1128/cdli.10.4.616-621.2003
发表时间:
2003-07-01
期刊:
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
影响因子:
--
作者:
Kim, KH;Yu, JU;Nahm, MH
通讯作者:
Nahm, MH
影响因子:
3.6
作者:
Gonzalez, BE;Hulten, KG;Mason, EO
通讯作者:
Mason, EO